Take a look inside this month's issue of Contemporary OB/GYN.
Three months after copper intrauterine device (IUD) insertion, nearly 1/3 of women were diagnosed with vulvovaginal candidiasis, compared to nearly 25% of women who received a hormonal IUD, according to a prospective study published in the journal Cellular and Molecular Biology.
Not only for football and safety but also for productivity and efficiency.
Laparoscopy remains the gold standard for diagnosis and treatment of the disease.
Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Although leadership in our post-pandemic climate is probably no more challenging than at any other time, it certainly feels that way.
Stay tuned for more articles as they go live!
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More